Cronos Group Inc

$2.68
Market Cap 1.02B
ROE -0.2%
Gross Margin 42.4%
Debt/Equity 0.0
Current Ratio 21.9
Revenue QoQ 40.1%
EPS QoQ 1.0%
F-Score 7

About

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach ®, PEACE NATURALS ® and Lord Jones ®.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-573.69
vs median 32.40
P/B
0.97
vs median 2.75
ROE
-0.00
vs median 0.12

High quality company with strong fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics